Cytokinetics.com

Site Inspections

Overview & More informations

Cytokinetics is a clinical-stage biotechnology company developing drugs that precisely target the mitotic process in cancer cells. The company's lead product candidate, reldesemtiv, is a small molecule inhibitor of the mitotic kinesin KSP, which is essential for cell division. Reldesemtiv is currently in Phase 3 clinical trials for the treatment of locally advanced and metastatic breast cancer, and Phase 2 clinical trials for the treatment of triple-negative breast cancer and other solid tumors.

Cytokinetics was founded in 1999 and is headquartered in South San Francisco, California. The company has a team of approximately 200 employees and has raised over $500 million in venture capital funding.

Cytokinetics' website provides information about the company's pipeline of drug candidates, clinical trials, and financial performance. The website also includes a section on the company's history and mission.

According to BuiltWith, Cytokinetics' website is built using the following technologies:

* Amazon Web Services (AWS)
* Google Analytics
* Google Tag Manager
* LinkedIn
* Twitter

Cytokinetics' website is also mobile-friendly and has a responsive design. The website is available in English, Chinese, French, German, Japanese, and Spanish.

According to SimilarWeb, Cytokinetics' website receives an average of 10,000 monthly visits. The website's top traffic sources are:

* Direct traffic (50%)
* Organic search (25%)
* Referral traffic (20%)
* Social media traffic (5%)

Cytokinetics' website is a valuable resource for information about the company and its products. The website is well-organized, easy to navigate, and provides a wealth of information.

Domains Expiration Date Updated